DR. PHAEDRA M. DOWELL M.D.
NPI 1437411725
Psychiatry & Neurology - Neurology in Overland Park, KS

Active since June 12, 2012
12140 NALL AVE STE 230, OVERLAND PARK, KS 66209(913) 661-9448(913) 661-4688 Get Directions Write a Review

NPPES record last updated: March 17, 2018. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Mar 17, 2018, Dec 19, 2017, Dec 13, 2017 (3 updates tracked since 2017).

About Dr. Phaedra M. Dowell M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. PHAEDRA M. DOWELL M.D. (NPI 1437411725) is an individual neurology provider in Overland Park, Kansas, licensed in Kansas (9407939) and active in the NPI registry since June 2012. She maintains a secondary practice location in Kansas City.

NPPES Registry Identity

NPI1437411725
Entity TypeIndividualFemale
Primary Taxonomy2084N0400X
Provider Legal NameDR. PHAEDRA M. DOWELLCredential: M.D.
Location Address12140 NALL AVE STE 230Overland Park, KS 66209-2507
Mailing Address12140 Nall Ave Ste 230Overland Park, KS 66209-2507 · (913) 661-9448 · Fax (913) 661-4688
Fax(913) 661-4688
Sole ProprietorYes
Enumeration DateJune 12, 2012
Last NPPES UpdateMarch 17, 20183 updates tracked since enumeration
NPI 1437411725 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyPsychiatry & Neurology · NeurologyAllopathic & Osteopathic Physicians
Taxonomy Code2084N0400X
License Licensed in KS · 9407939
Definition
A Neurologist specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
12140 NALL AVE STE 230, Overland Park, KS 66209

Secondary Practice Location 1

Location 13901 Rainbow Blvd, MS 2012Kansas City, KS 66103-2937 · Phone (913) 588-6970 · Fax (913) 588-6965

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

Reported Quality Measures

Depression Utilization of the PHQ-9 Tool
The percentage of patients age 18 and older with the diagnosis of major depression or dysthymia who have a completed PHQ-9 during each applicable 4 month period in which there was a qualifying visit
3%32 patients
Diabetes: Medical Attention for Nephropathy
The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period
87%68 patients4/55-star benchmark: 99%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
72%1,338 patients1/55-star benchmark: 99%
Falls: Screening for Future Fall Risk
Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period
75%487 patients4/55-star benchmark: 99%
Health Information Exchange
The MIPS eligible clinician that transitions or refers their patient to another setting of care or health care clinician (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving health care clinician for…
26%414 patients2/55-star benchmark: 88%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
93%513 patients3/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
93%801 patients4/55-star benchmark: 97%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous…
38%798 patients2/55-star benchmark: 97%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
23%544 patients2/55-star benchmark: 88%
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
Percentage of patients aged 12 years and older screened for depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen
9%716 patients1/55-star benchmark: 96%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
100%801 patients5/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
18%801 patients1/55-star benchmark: 89%
Use of High-Risk Medications in the Elderly
Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication.
Lower rates are better for this measure.
Patients 2+: 0% · 476 patients
1%476 patients4/55-star benchmark: 100%
View, Download, or Transmit (VDT)
At least one patient seen by the MIPS eligible clinician during the performance period (or patient-authorized representative) views, downloads or transmits their health information to a third party during the performance period.
16%801 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Phaedra Dowell's NPI number?

The NPI number for Phaedra Dowell is 1437411725. It was assigned to this individual provider in the NPPES registry on June 12, 2012.

Where is Phaedra Dowell located?

Phaedra Dowell practices at 12140 Nall Ave Ste 230, Overland Park, KS 66209. The listed phone number is (913) 661-9448.

What is Phaedra Dowell's specialty?

The primary specialty registered for this NPI is Psychiatry & Neurology, specializing in Neurology, with taxonomy code 2084N0400X.

When was this NPI record last updated?

The NPPES record for Phaedra Dowell was last updated on March 17, 2018. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 8 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.